BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23727642)

  • 1. Medium-chain triacylglycerol suppresses the decrease of plasma albumin level through the insulin-Akt-mTOR pathway in the livers of malnourished rats.
    Sekine S; Terada S; Aoyama T
    J Nutr Sci Vitaminol (Tokyo); 2013; 59(2):123-8. PubMed ID: 23727642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serine 302 Phosphorylation of Mouse Insulin Receptor Substrate 1 (IRS1) Is Dispensable for Normal Insulin Signaling and Feedback Regulation by Hepatic S6 Kinase.
    Copps KD; Hançer NJ; Qiu W; White MF
    J Biol Chem; 2016 Apr; 291(16):8602-17. PubMed ID: 26846849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citrulline directly modulates muscle protein synthesis via the PI3K/MAPK/4E-BP1 pathway in a malnourished state: evidence from in vivo, ex vivo, and in vitro studies.
    Le Plénier S; Goron A; Sotiropoulos A; Archambault E; Guihenneuc C; Walrand S; Salles J; Jourdan M; Neveux N; Cynober L; Moinard C
    Am J Physiol Endocrinol Metab; 2017 Jan; 312(1):E27-E36. PubMed ID: 27827806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dietary medium-chain triacylglycerol on mRNA level of gluconeogenic enzymes in malnourished rats.
    Kojima K; Kasai M
    J Nutr Sci Vitaminol (Tokyo); 2008 Dec; 54(6):507-10. PubMed ID: 19155591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.
    Khamzina L; Veilleux A; Bergeron S; Marette A
    Endocrinology; 2005 Mar; 146(3):1473-81. PubMed ID: 15604215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotoxin disrupts the leucine-signaling pathway involving phosphorylation of mTOR, 4E-BP1, and S6K1 in skeletal muscle.
    Lang CH; Frost RA
    J Cell Physiol; 2005 Apr; 203(1):144-55. PubMed ID: 15389631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle.
    Tandelilin AA; Hirase T; Hudoyo AW; Cheng J; Toyama K; Morisaki H; Morisaki T
    BMC Endocr Disord; 2015 Mar; 15():11. PubMed ID: 25887856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal protein restriction in the rat inhibits placental insulin, mTOR, and STAT3 signaling and down-regulates placental amino acid transporters.
    Rosario FJ; Jansson N; Kanai Y; Prasad PD; Powell TL; Jansson T
    Endocrinology; 2011 Mar; 152(3):1119-29. PubMed ID: 21285325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino Acid-Induced Activation of mTORC1 in Rat Liver Is Attenuated by Short-Term Consumption of a High-Fat Diet.
    Kimball SR; Ravi S; Gordon BS; Dennis MD; Jefferson LS
    J Nutr; 2015 Nov; 145(11):2496-502. PubMed ID: 26400964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adding protein to a carbohydrate supplement provided after endurance exercise enhances 4E-BP1 and RPS6 signaling in skeletal muscle.
    Morrison PJ; Hara D; Ding Z; Ivy JL
    J Appl Physiol (1985); 2008 Apr; 104(4):1029-36. PubMed ID: 18239077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERK1/2-dependent activation of mTOR/mTORC1/p70S6K regulates thrombin-induced RPE cell proliferation.
    Parrales A; López E; Lee-Rivera I; López-Colomé AM
    Cell Signal; 2013 Apr; 25(4):829-38. PubMed ID: 23291002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatase control of 4E-BP1 phosphorylation state is central for glycolytic regulation of retinal protein synthesis.
    Gardner TW; Abcouwer SF; Losiewicz MK; Fort PE
    Am J Physiol Endocrinol Metab; 2015 Sep; 309(6):E546-56. PubMed ID: 26199279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammalian target of rapamycin is activated in association with myometrial proliferation during pregnancy.
    Jaffer S; Shynlova O; Lye S
    Endocrinology; 2009 Oct; 150(10):4672-80. PubMed ID: 19589861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling from Akt to FRAP/TOR targets both 4E-BP and S6K in Drosophila melanogaster.
    Miron M; Lasko P; Sonenberg N
    Mol Cell Biol; 2003 Dec; 23(24):9117-26. PubMed ID: 14645523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMPK activation attenuates S6K1, 4E-BP1, and eEF2 signaling responses to high-frequency electrically stimulated skeletal muscle contractions.
    Thomson DM; Fick CA; Gordon SE
    J Appl Physiol (1985); 2008 Mar; 104(3):625-32. PubMed ID: 18187610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.
    Joassard OR; Amirouche A; Gallot YS; Desgeorges MM; Castells J; Durieux AC; Berthon P; Freyssenet DG
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2444-55. PubMed ID: 23916784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of cell-signaling pathways in the regulation of mammalian target of rapamycin (mTOR) by amino acids in rat adipocytes.
    Pham PT; Heydrick SJ; Fox HL; Kimball SR; Jefferson LS; Lynch CJ
    J Cell Biochem; 2000 Sep; 79(3):427-41. PubMed ID: 10972980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological inhibition of S6K1 increases glucose metabolism and Akt signalling in vitro and in diet-induced obese mice.
    Shum M; Bellmann K; St-Pierre P; Marette A
    Diabetologia; 2016 Mar; 59(3):592-603. PubMed ID: 26733005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
    J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin signaling during perinatal liver development in the rat.
    Anand P; Boylan JM; Ou Y; Gruppuso PA
    Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E844-52. PubMed ID: 12217903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.